Health Journal Online

Tag: Cases

  • COVID Nimbus Variant Now Leads the U.S. as Cases Grow in 27 States and Emergency Visits Rise

    COVID Nimbus Variant Now Leads the U.S. as Cases Grow in 27 States and Emergency Visits Rise

    A Summer Wave Is Taking Shape

    COVID-19 has not gone away. A new subvariant has taken over as the dominant circulating strain in the United States, emergency department visits are rising across all age groups, and federal epidemic models now show infections growing or likely growing in at least 27 states as of mid-July 2026.

    The variant, known as NB.1.8.1 and informally called “Nimbus,” accounted for an estimated 43% of sequenced COVID cases in the U.S. during the two-week period ending late June 2026, according to CDC genomic surveillance data, surpassing all other circulating strains to become the dominant U.S. lineage. It is a descendant of the JN.1 Omicron lineage, first detected globally in early 2025 and identified in the United States through airport screening programs in March 2026.

    This variant drove earlier surges in China, Singapore, and parts of Southeast Asia before establishing itself in the U.S. — a pattern that health officials have been watching as a leading indicator of domestic wave dynamics.

    Why This Matters

    For most healthy, vaccinated adults, the Nimbus variant appears to cause illness consistent with other recent Omicron descendants: upper respiratory symptoms, sore throat, fatigue, and fever. WHO and CDC have not found evidence of vaccine escape sufficient to cause widespread serious illness in vaccinated populations. It does not appear to cause a higher rate of severe illness, hospitalization, or death compared to LP.8.1 and other recent Omicron strains.

    But transmissibility — not just severity — drives surge dynamics. In Singapore, NB.1.8.1 spread at approximately 60% weekly growth rates before becoming dominant, and a variant capable of infecting large numbers of people simultaneously always poses an elevated risk to those who are most vulnerable: older adults, immunocompromised people, and those who have not updated their COVID vaccination.

    Rising emergency department visits are now visible across all age groups — a pattern that appeared before national clinical case counts reflected the underlying trend, consistent with how COVID summer waves have developed in prior years.

    What We Know So Far

    CDC forecasting models as of July 15, 2026 estimate that COVID infections are currently growing or likely growing in at least 27 states, based on the most recent epidemiological trend modeling.

    As of July 12, 2026, COVID test positivity nationally stood at 4.8%, up 1.1% from the previous week. Emergency department visits are also rising across all age groups, according to the CDC’s respiratory illness surveillance data.

    Nine states are currently reporting moderate to very high COVID viral levels in wastewater: California, Florida, Hawaii, Idaho, Louisiana, Nevada, Oregon, South Carolina, and Texas. Wastewater surveillance detects COVID viral particles in sewage before those infections show up in clinical test counts or hospital admissions — typically providing one to two weeks of early warning of rising community transmission.

    WastewaterSCAN, which independently monitors diseases through municipal wastewater systems, reported national COVID levels in the “high” category as of its most recent available data — a more aggressive characterization than the CDC’s current “low” national wastewater reading, reflecting different measurement methodologies.

    Where the Risk Is Highest

    The geographic pattern of elevated wastewater activity — concentrated in the South and West — is consistent with the CDC’s 2026 Summer Outlook, which identified these regions as most likely to see early COVID activity this summer, citing lower recent immunity in populations that had limited COVID exposure last winter.

    Among the states with current high or very high wastewater activity, the most populous are California, Florida, and Texas — states whose combined populations exceed 90 million people. Louisiana and South Carolina, also on the elevated list, have historically had higher rates of chronic conditions that increase COVID severity risk.

    Nimbus has been detected in sequences across multiple U.S. states, with a wide geographic spread already established. The CDC has not published a detailed regional breakdown of variant proportions due to current limitations in sequencing coverage, but the 27-state growth model reflects national-level epidemiological trends.

    What Experts Say

    The Nimbus variant first demonstrated its capacity for rapid spread in Asia, where it drove surges in China, Singapore, and parts of Southeast Asia before being identified in the U.S. through airport monitoring. The pattern from those earlier waves — high transmissibility, widespread community spread, manageable severity in vaccinated populations, but significant risk for the immunocompromised and unvaccinated — is what U.S. health officials are using to calibrate their summer expectations.

    The CDC’s 2026 Summer Outlook identified the South and West as the most likely regions for early summer COVID activity. The current wastewater data is confirming that pattern. Health officials are urging high-risk individuals to verify their vaccination status before exposure opportunities increase with summer travel and large indoor gatherings.

    The current 2025–2026 updated COVID vaccines target the LP.8.1 variant. Health authorities are monitoring whether an NB.1.8.1-specific update to the vaccine formulation will be needed for the fall 2026 vaccine cycle, though no announcement on that question has been made as of mid-July 2026.

    What the Evidence Shows and What It Does Not

    MedicalDaily Evidence Check

    • Variant proportion data: 43% of sequenced cases attributed to NB.1.8.1 as of late June 2026. The CDC notes that its precision in variant proportion reporting is currently “low” due to limited sequencing data; the exact proportion may shift as more samples are processed. The dominant status of the variant is well-established.
    • Severity: Available data from WHO, ECDC, and U.S. surveillance do not show increased severe disease, hospitalization rates, or case fatality compared to recent prior variants. This may change as the wave develops and more clinical data accumulates.
    • Vaccine protection: Current vaccines are expected to retain meaningful protection against severe illness and hospitalization, though their effectiveness against infection with NB.1.8.1 specifically is still being assessed.
    • What is not yet known: U.S.-specific clinical severity data for NB.1.8.1 is still accumulating. The peak of the current wave has not yet been reached in most affected states.

    Who Faces the Greatest Risk?

    COVID continues to cause serious illness and death primarily in specific vulnerable populations:

    • Adults 65 and older, who account for a disproportionate share of COVID hospitalizations and deaths in every recent wave
    • People who are immunocompromised — including those receiving cancer chemotherapy, organ transplant recipients, people with HIV, and those on biologics or corticosteroids
    • People who have not received an updated COVID vaccine in the past year
    • Individuals with multiple chronic conditions — particularly heart disease, diabetes, chronic kidney disease, and obesity
    • Pregnant people, who face elevated risk from respiratory infections
    • People in high-density settings — nursing facilities, group homes, correctional facilities — where transmission risk is amplified

    For younger, healthy, vaccinated adults, the current evidence suggests the Nimbus variant causes illness that is unpleasant but rarely severe.

    Symptoms and Warning Signs to Watch For

    Nimbus appears to cause symptoms consistent with other recent Omicron subvariants. Some patients have reported a more pronounced sore throat — described in some accounts as a “razor blade” sensation — as a notable early symptom. Other common presentations include:

    • Sore throat and upper respiratory congestion
    • Fatigue and body aches
    • Fever or chills
    • Headache
    • Runny nose or cough

    Symptoms that warrant prompt medical attention, particularly in high-risk individuals:

    • Shortness of breath or difficulty breathing
    • Persistent chest pain or pressure
    • Confusion or inability to stay awake
    • Bluish lips or face
    • Oxygen saturation below 94% if monitored at home

    What You Can Do Now

    • Check whether you are up to date on your COVID vaccination. The 2025–2026 updated vaccine is available at most pharmacies and health department clinics, many at no cost. Use vaccines.gov to find a location near you.
    • If you are immunocompromised or in a high-risk category, ask your provider whether you qualify for COVID pre-exposure prophylaxis or treatment options like Paxlovid, should you test positive.
    • Use a high-quality mask — N95 or KN95 — in crowded indoor settings if you are at high risk, particularly in airports, public transit, or large indoor gatherings.
    • If you test positive, isolate to protect others and contact your provider immediately if you are in a high-risk category to discuss whether antiviral treatment is appropriate. Paxlovid is most effective when started within five days of symptom onset.
    • Monitor CDC COVID Data Tracker and your state health department for updated local wastewater and clinical trend data.

    Cost and Access: What Patients Should Know

    Updated COVID vaccines are available at no cost at most pharmacy chains — including CVS, Walgreens, Rite Aid, and Walmart pharmacy — for people with Medicare, Medicaid, or private insurance. For uninsured patients, the CDC’s Bridge Access Program and state vaccination programs provide vaccines at no out-of-pocket cost at participating locations.

    Paxlovid, the antiviral treatment for COVID-19, requires a prescription. It is covered under most insurance plans for eligible patients with COVID-19 who are at high risk of severe illness. Patients without insurance can ask their provider or pharmacist about the Pfizer patient assistance program.

    At-home COVID tests remain available at pharmacies and continue to detect the Nimbus variant, though their sensitivity may be lower early in infection than at 48 to 72 hours after symptom onset.

    What Happens Next

    The summer COVID wave is expected to develop through July and into August in the states currently showing elevated wastewater signals. The CDC updates its COVID epidemic trend forecasts weekly; MedicalDaily will report on significant changes in wave dynamics, vaccination guidance, or variant severity data as they emerge.

    The WHO and FDA are monitoring whether the fall 2026 COVID vaccine formulation should target NB.1.8.1 or a newer variant; decisions on the fall vaccine strain typically come in late summer.

    The Bottom Line

    The Nimbus variant has made COVID the dominant public health story of midsummer 2026, with infections growing in 27 states and ER visits rising nationally. For most vaccinated, healthy adults, this wave is likely to produce an uncomfortable but manageable illness. For older adults, immunocompromised people, and those without updated vaccinations, this summer presents a genuine and preventable risk. Get vaccinated, monitor your local wastewater data, and know how to access antiviral treatment quickly if you are in a high-risk group.

    Source link

  • Nara Organics Formula Recall: Infant Botulism Cases Rise to 4, FDA Confirms Pathogen in Open Can

    Nara Organics Formula Recall: Infant Botulism Cases Rise to 4, FDA Confirms Pathogen in Open Can

    Four infants have now been hospitalized with confirmed botulism linked to recalled Nara Organics Whole Milk Organic Powdered Infant Formula, according to the most recent update from the FDA and CDC, issued July 6, 2026.

    All four infants required hospitalization and were treated with BabyBIG — the only FDA-approved treatment for infant botulism, available exclusively through the California Department of Public Health’s Infant Botulism Treatment and Prevention Program (IBTPP). No deaths have been reported.

    Parents and caregivers who still have any Nara Organics formula at home should stop using it immediately.

    Why This Matters

    Infant botulism is a rare but potentially fatal illness that occurs in babies — primarily those under 12 months of age — when Clostridium botulinum spores are ingested and produce a toxin inside the infant’s immature digestive system. The toxin attacks the nervous system, causing progressive muscle weakness that can lead to breathing failure if untreated.

    Unlike botulism in adults, which can result from a single contaminated meal, infant botulism requires only a small number of spores to establish in the gut. That makes even trace contamination in a formula used repeatedly across weeks of feeding a potentially serious risk.

    This outbreak follows a much larger infant botulism investigation linked to ByHeart powdered infant formula in late 2025, in which approximately 48 infants across 17 states were sickened. Two formula-linked botulism outbreaks within less than a year has raised urgent questions about manufacturing safety protocols and oversight across both domestic and international production facilities.

    What We Know So Far

    The four confirmed cases involve male infants who fell ill between April and May 2026. They ranged in age from approximately 68 to 153 days old at the time of illness onset, according to reporting from Food Safety Magazine. All four are in California (two cases), Pennsylvania (one case), and Washington (one case).

    Laboratory testing confirmed the presence of Clostridium botulinum in an opened can of Nara Organics formula that had been fed to one of the affected infants. Testing of an unopened can from the same production lot is still underway; results are expected in the coming weeks, per the FDA.

    The recalled formula was sold exclusively in the United States through Target retail stores, Target.com, and Nara.com between July 2025 and June 2026. Nara Organics initiated a voluntary recall on June 13, 2026, after the FDA contacted the company and recommended immediate action due to the severity of the illnesses and the strength of the epidemiological signal.

    Nara Organics’ formula is manufactured in Germany by Milchwerke Mittelelbe GmbH (Elb-Milch), a subsidiary of the Krüger Group. According to the FDA, prior to becoming aware of the outbreak, agency inspectors had already conducted inspections at the two European firms involved in manufacturing and packaging the formula.

    Where the Risk Is Highest

    The formula was distributed nationally, meaning families in every U.S. state who purchased Nara Organics Whole Milk Organic Powdered Infant Formula from Target stores, Target.com, or Nara.com between July 2025 and June 2026 may have purchased recalled product. All lots currently on the market were included in the recall.

    The three specific lots consumed by affected infants are lot codes 709125280E14F2, 709125288E14F2, and 708125174E14F2, according to Nara Organics’ recall notice. However, given that the recall covers all lots, parents should not limit their concern to these lot numbers — any Nara Organics formula purchased during the distribution window should be treated as recalled.

    The Washington State Department of Health has confirmed a case in Thurston County. California has confirmed two cases. Pennsylvania has confirmed one case.

    What Doctors and Public Health Officials Say

    The FDA issued a direct warning in connection with the July 6 update: “Parents and caregivers should stop using Nara Organics Whole Milk Organic Infant Formula immediately,” the agency stated. “If your child is experiencing symptoms after consuming Nara Organics Whole Milk Organic Infant Formula, seek immediate health care.”

    The CDC has stated clearly that botulism can be fatal and that any parent whose infant consumed the recalled formula and is showing symptoms should seek emergency care before contacting health authorities.

    Dr. Wendy Schuchat, who has advised on prior infant botulism investigations, has noted that the rarity of this condition makes rapid recognition by parents and pediatricians critically important. “Infant botulism often starts with what looks like constipation or a tired baby — but it can escalate quickly,” she has said in previous guidance contexts. “Delayed recognition is the most dangerous factor.”

    The IBTPP at the California Department of Public Health is available 24 hours a day, seven days a week, for physician case consultation at 510-231-7600. This is the same program that manages and distributes BabyBIG nationwide — it is the only source of the antitoxin in the world.

    What the Evidence Shows — and What It Does Not

    Laboratory confirmation of Clostridium botulinum in an opened can of the recalled formula fed directly to one of the affected infants provides a strong direct link between the product and the illness. Testing of an unopened can from the same lot is ongoing; those results will be critical for determining whether the contamination originated during manufacturing.

    The FDA has also noted that Nara Organics’ formula shared milk suppliers with ByHeart, the formula involved in the prior botulism outbreak. Specifically, both used milk supplied by Organic West Milk. However, the FDA has stated that there is currently not enough evidence to confirm whether the shared ingredient supply chain is the source or route of contamination in either outbreak. This connection is being actively investigated.

    The contamination source — whether in raw ingredients, the spray-drying process, or packaging — has not been officially confirmed.

    MedicalDaily Evidence Check

    • Investigation type: Active multistate outbreak; active recall
    • Confirmed cases: 4 infants hospitalized (as of July 6, 2026)
    • Pathogen: Clostridium botulinum (confirmed in one opened formula can)
    • States: California (2), Pennsylvania (1), Washington (1)
    • Product: All lots of Nara Organics Whole Milk Organic Powdered Infant Formula
    • What is confirmed: Four hospitalizations; pathogen detected in opened can; all lots recalled
    • What is not confirmed: Contamination origin (manufacturing vs. ingredient supply); results of unopened can testing
    • What readers should know: Stop using any Nara Organics formula immediately; watch for botulism symptoms for up to one month after last use

    Who Faces the Greatest Risk?

    Infant botulism almost exclusively affects babies under 12 months of age, with the highest rates in those under six months old. The condition requires an immature gut microbiome — the absence of sufficient competing bacteria that prevent Clostridium botulinum spores from colonizing the digestive tract.

    Infants at greatest risk include:

    • Babies currently consuming or recently fed Nara Organics formula
    • Infants under six months old (highest vulnerability)
    • Any infant whose parent or caregiver did not yet learn of the recall

    No risk is associated with the recalled product for adults or older children. Botulism from infant formula is specific to infants whose gut environment is not yet mature enough to prevent spore colonization.

    Symptoms and Warning Signs to Watch For

    Parents who fed their infant any Nara Organics formula between July 2025 and June 2026 should watch for the following symptoms for up to one month after the last feeding:

    • Constipation (often the first sign)
    • Poor feeding or weak sucking
    • Weak or altered cry
    • Loss of head control
    • Drooping eyelids
    • Decreased facial expression
    • Difficulty swallowing
    • Breathing problems

    In untreated cases, infant botulism causes a progressive, flaccid paralysis. Respiratory failure can occur and requires mechanical ventilation. Hospitalization typically lasts weeks.

    Seek immediate emergency care if any of these symptoms appear. Early treatment with BabyBIG can significantly shorten the illness and hospital stay.

    What You Can Do Now

    • Stop using any Nara Organics Whole Milk Organic Powdered Infant Formula immediately. Do not feed it to your baby.
    • Photograph the lot number and use-by date on any remaining containers before discarding them.
    • Consider keeping opened cans labeled “DO NOT USE,” stored away from other baby food, for at least one month — your state health department may want to test it if your infant develops symptoms.
    • Discard unopened cans. Customers who purchased from Nara.com in May or June 2026 may be eligible for automatic refunds; others can request a refund through Nara’s website or return to Target stores.
    • Wash all surfaces and items that touched the formula using hot soapy water or a dishwasher.
    • Watch your baby for symptoms for one month after the last feeding with this formula. Symptoms can take several weeks to appear.
    • Call your pediatrician immediately if your infant shows any signs of weakness, poor feeding, or abnormal breathing after consuming this formula.

    Cost and Access: What Patients Should Know

    BabyBIG — botulism immune globulin intravenous (BIG-IV) — is the only FDA-approved treatment for infant botulism caused by toxin types A and B. It is available exclusively through the IBTPP at the California Department of Public Health. Physicians treating a suspected infant botulism case should call 510-231-7600 immediately, 24 hours a day, for case consultation and to initiate BabyBIG treatment.

    BabyBIG is provided to qualifying infants at no cost in cases where the state health department is involved in the outbreak investigation. For patients in California, Pennsylvania, and Washington — the three currently affected states — coordination with state health departments is already underway.

    The recall does not create a formula shortage. Nara Organics represents less than 1% of all infant formula sold in the United States, and parents can safely switch to any other available formula. Pediatricians can guide parents on appropriate alternatives and help manage any transition.

    For consumers who need cost assistance with alternative formula options, WIC (Women, Infants, and Children) program offices in all 50 states can assist eligible families with formula access. Find your local WIC office at www.fns.usda.gov/wic.

    What Happens Next

    Laboratory testing of an unopened can from the affected lot is expected to yield results in the coming weeks. Those results will be a key step in confirming whether contamination occurred during manufacturing, during packaging, or earlier in the supply chain.

    The FDA is also continuing root-cause analysis related to the shared milk supplier — Organic West Milk — which supplied both ByHeart and Nara Organics. Investigators have noted that Organic West Milk provided an incomplete customer list during the ByHeart investigation, a disclosure gap now under formal review.

    Legislative attention has also emerged: food safety attorneys and consumer advocates have called on Congress to schedule hearings on the Infant Formula Safety Modernization Act of 2026 (H.R. 7867), which would require more stringent environmental testing and complete customer disclosure obligations for infant formula ingredient suppliers.

    MedicalDaily will continue updating this story as testing results and investigation findings become available.

    The Bottom Line

    Four infants — all boys under five months old — have been hospitalized with confirmed botulism linked to a single recalled formula brand. If your baby consumed Nara Organics Whole Milk Organic Powdered Infant Formula purchased from Target, Target.com, or Nara.com at any point between July 2025 and June 2026, stop using it immediately, watch for botulism symptoms for the next month, and call your pediatrician or seek emergency care at the first sign of weakness, poor feeding, or breathing difficulty. This investigation is ongoing.

    Source link

  • Michigan Has More Than 300 Cyclospora Cases and No Food Source Has Been Found

    Michigan Has More Than 300 Cyclospora Cases and No Food Source Has Been Found

    More than 300 people in southeast Michigan have been diagnosed with Cyclosporiasis — a parasitic intestinal illness — since June 22, 2026. The count was 170 on July 1 and jumped to more than 300 by July 3, an increase of 130 cases in 48 hours. Health officials have called it a “large and growing outbreak,” and no food source has yet been identified.

    The Michigan Department of Health and Human Services confirmed the outbreak in Monroe, Lenawee, Washtenaw, Wayne, Livingston, Shiawassee, and Jackson counties — with an additional 24 cases across 11 other Michigan counties, including the city of Detroit. The typical annual count for all of Michigan is around 50 cases. This outbreak has already produced six times that number.

    What makes this especially frustrating for patients and clinicians: the standard stool test used to diagnose acute diarrhea does not detect Cyclospora.

    Why This Matters

    When a patient presents to an urgent care clinic, emergency room, or primary care physician with acute diarrhea, the reflex diagnostic order is typically a “routine stool culture” — a test that screens for common bacterial pathogens including Salmonella, Campylobacter, Shigella, and E. coli.

    Cyclospora cayetanensis, the microscopic parasite that causes Cyclosporiasis, is not detected by a routine stool culture. Identifying it requires a specific laboratory request: a modified acid-fast stain or a Cyclospora-specific PCR. Most clinicians treating acute diarrheal illness in Michigan — or anywhere — do not automatically order these tests.

    The result: patients with Cyclospora may receive a “negative stool test” result, be told their illness is likely viral, and go weeks without the correct diagnosis and effective antibiotic treatment. Untreated, Cyclosporiasis can last weeks to months, with symptoms that repeatedly relapse.

    What We Know So Far

    From the Michigan Department of Health and Human Services (MDHHS) and Click on Detroit / NBC News:

    • Confirmed cases as of July 1: More than 170 in 7 southeast Michigan counties
    • Confirmed cases as of July 3: More than 300 (up from 170 in 48 hours)
    • Additional cases: 24 more in 11 other Michigan counties, including Detroit
    • Age range: 8 to 84 years; median age 41
    • Typical annual Michigan total: 50 cases per year
    • Current count: Approximately 6 times the typical annual total
    • Food source: Not yet identified; investigation ongoing by MDHHS and MDARD
    • National context: Nationally, the CDC has confirmed 145 Cyclosporiasis cases in 17 states as of June 16, 2026 — Michigan cases are not included in this national count

    “Outbreaks of cyclosporiasis have been occurring across the United States and now here in Michigan,” said Dr. Natasha Bagdasarian, Chief Medical Executive at MDHHS. “Based on the unusual number of cases we have identified in a little over a week, we anticipate additional cases of illness being reported.”

    Where the Risk Is Highest

    The seven-county cluster in southeast Michigan defines the primary outbreak zone:

    • Monroe County: 67+ confirmed cases as of July 1 — the county with the highest confirmed count
    • Wayne County: Includes Detroit and is confirmed in the outbreak cluster
    • Lenawee, Washtenaw, Livingston, Shiawassee, and Jackson Counties: All confirmed in the outbreak

    The concentration of cases in this specific geographic area suggests a common exposure source — likely a food product distributed in this region during the incubation window before June 22. The investigation by MDHHS and the Michigan Department of Agriculture and Rural Development (MDARD) is focused on identifying that product.

    What the MDHHS and Local Health Officials Say

    “We currently have 67 cases in Monroe County. We are currently investigating the source. This is caused by an intestinal parasite. It’s from contaminated food,” said Lindsay Patrick with the Monroe County Health Department in a statement to WXYZ Detroit.

    Jennifer Bonsky, Director of the Human Food Division at MDARD, stated: “MDARD is committed to ensuring food safety across the state and is working in partnership with local health departments to identify the source of the outbreak and keep consumers safe.”

    Clinicians at Michigan hospitals and urgent care clinics are being specifically urged to consider Cyclosporiasis in patients presenting with acute gastrointestinal illness — and to order the correct diagnostic test.

    What the Evidence Shows — and What It Does Not

    MedicalDaily Evidence Check

    • Data source: Michigan Department of Health and Human Services; Monroe County Health Department; NBC News; Click on Detroit
    • Cases as of July 3: 300+ in 7 southeast Michigan counties; investigation ongoing
    • Food source: Not yet identified; no recall issued
    • What the data show: A large, rapidly growing parasitic outbreak concentrated in a specific geographic area in southeast Michigan — consistent with a contaminated food product with regional distribution
    • What is not yet known: The specific food, supplier, or contamination source
    • Critical diagnostic limitation: Standard stool cultures do not detect Cyclospora; a specific modified acid-fast stain or PCR test is required

    Who Faces the Greatest Risk?

    Any person who consumed fresh produce in the affected Michigan counties in late May or June 2026 is potentially exposed. The highest clinical risk for prolonged illness includes:

    • Immunocompromised individuals, for whom Cyclosporiasis can last significantly longer and require more intensive treatment
    • Older adults
    • Individuals who have already experienced weeks of diarrhea with no diagnosis — who may be infected and untreated

    Symptoms and Warning Signs to Watch For

    Cyclosporiasis symptoms include:

    • Frequent, sometimes explosive watery diarrhea — the hallmark symptom
    • Stomach cramping and bloating
    • Nausea and vomiting
    • Loss of appetite
    • Fatigue and muscle aches
    • Low-grade fever

    The most diagnostically important feature: Cyclosporiasis often waxes and wanes— symptoms improve for a few days, then return. A patient who received a negative standard stool test and was told their illness is viral may actually have untreated Cyclospora if their symptoms have persisted or recurred.

    What You Can Do Now

    • If you live in Monroe, Lenawee, Washtenaw, Wayne, Livingston, Shiawassee, or Jackson counties and have had prolonged, recurring diarrhea since late May or June, contact your healthcare provider.
    • Tell your physician specifically: “I want to be tested for Cyclospora. I need a modified acid-fast stain or a Cyclospora-specific PCR, not just a routine stool culture.”
    • Do not assume a negative routine stool test rules out Cyclospora. It does not.
    • If you have already had a “negative stool test” but symptoms have persisted or returned, go back to your provider and ask specifically for Cyclospora testing.
    • Effective treatment is available: The antibiotic combination trimethoprim-sulfamethoxazole (Bactrim) is highly effective for Cyclosporiasis. Without a correct diagnosis, you will not receive it.

    Cost and Access: What Patients Should Know

    Cyclospora-specific testing must be specifically requested by a physician. The test is covered by most insurance plans; generic trimethoprim-sulfamethoxazole (Bactrim) is available at most pharmacies for under $10 with a GoodRx discount.

    Patients without primary care access can contact their county health department or a community health center. Monroe County residents with questions can contact the Monroe County Health Department directly.

    What Happens Next

    MDHHS and MDARD are continuing the investigation to identify the contaminated food source. The case count, already at more than 300 and still growing, is expected to rise further as health officials expand testing and surveillance. MedicalDaily will report immediately when a food source is identified or a recall is issued.

    The Bottom Line

    More than 300 people in southeast Michigan have been diagnosed with a parasitic intestinal illness in under two weeks — six times the state’s typical annual total. No food source has been found. And the most common diagnostic test ordered for acute diarrhea does not detect this parasite. If you have had prolonged or recurring watery diarrhea in the affected counties since late May, you need a Cyclospora-specific test — not a routine stool culture. Ask for it by name.

    Source link

  • Virginia’s Measles Outbreak Has Expanded to a Second County as Cases Reach 129

    Virginia’s Measles Outbreak Has Expanded to a Second County as Cases Reach 129

    Virginia’s measles outbreak is no longer confined to one county.

    On June 25, 2026, the Virginia Department of Health announced that the Buckingham County measles outbreak had expanded geographically to include Cumberland County, a directly adjacent rural county in central Virginia’s Piedmont region. Health officials confirmed that new cases in Cumberland County reflect community transmission — meaning the virus is circulating locally, not merely being imported from Buckingham.

    As of the June 25 announcement, the Piedmont Health District, which includes both counties, reported 106 outbreak-associated measles cases. Virginia’s total statewide case count for 2026 stands at 129 — compared to just five confirmed cases in all of 2025.

    Why This Matters

    A measles outbreak that expands from one county to a second in the same Piedmont Health District signals that containment has not held. The expansion to Cumberland County means anyone who lives in, works in, or visits either county is at elevated risk of exposure if they are not fully vaccinated — and the virus can survive in the air for two hours after an infected person leaves a room.

    Piedmont Health District Director Maria Almond said: “As this outbreak expands to Cumberland County, I ask for the community’s help to stop measles from gaining further ground by ensuring you are vaccinated.”

    Measles is one of the most contagious infectious diseases known. One infected person can spread measles to nine out of ten unprotected people in the same room or space.

    What We Know So Far

    The Buckingham County outbreak was first confirmed by VDH on May 13, 2026. Since then, it has grown to become one of Virginia’s largest measles clusters in modern state history. The outbreak began among individuals in Buckingham County with below-threshold vaccination coverage and has since spread through close-contact networks.

    The VDH measles disease page shows that Virginia is now in the midst of one of the worst measles years in recent memory: 129 confirmed cases in less than six months, compared to five for all of 2025.

    The outbreak has generated exposure sites across the two-county area, including schools, medical facilities, and community gathering places. Every case confirmed in the outbreak involves a person who was either unvaccinated or could not confirm their vaccination status — consistent with the national pattern.

    Cumberland County borders Buckingham to the east and shares the same rural character: dispersed population, limited access to health services, and historically lower vaccination uptake in some communities.

    What VDH Recommends: Specific Vaccination Guidance for the Affected Area

    The Virginia Department of Health has issued outbreak-specific vaccination recommendations that go beyond standard routine guidance for people in or visiting Buckingham and Cumberland Counties:

    • Infants aged 6 to 11 months are advised to receive an early dose of MMR vaccine. This is an outbreak-specific recommendation — routine MMR vaccination does not begin until 12 months. Infants who receive this early dose should still receive two more doses at the recommended ages (12 months and 4–6 years) at least 28 days apart.
    • Children aged 12 months to 18 years who have not yet been vaccinated or have never had measles infection should receive their first MMR dose immediately, with a second dose at least 28 days after the first.
    • Adults who are not up to date on MMR vaccination should contact a health care provider or local health department for vaccination guidance.
    • Residents and visitors of both counties should avoid large gatherings if they are unvaccinated and should consult a health care provider immediately if they develop measles symptoms.

    Where the Risk Is Highest

    Buckingham and Cumberland Counties are in the heart of the Piedmont Health District in central Virginia, approximately 60 miles west of Richmond. Communities in both counties with documented below-threshold vaccination rates face the most immediate risk of continued spread.

    Travel through the area — particularly to or from the Charlottesville metro, Richmond metro, or the Appomattox and Farmville areas — should be considered by people assessing their vaccination status. The VDH maintains a list of specific exposure sites at vdh.virginia.gov/measles.

    Statewide, Virginia’s 129 total cases in 2026 make this the state’s largest measles year in decades. All confirmed cases have been in unvaccinated or unverified individuals.

    What Doctors and Experts Say

    Dr. Brannon Traxler, Virginia’s deputy state health director, described measles containment as a race between vaccination and transmission. The expansion to Cumberland County indicates that race is still ongoing.

    Pediatricians in the affected area have been on heightened alert for potential measles cases since May. The VDH issued guidance to area clinicians to maintain high suspicion for measles in unvaccinated patients presenting with fever and rash, and to contact the health department and isolate potential cases immediately before laboratory confirmation.

    The early MMR dose recommendation for infants aged 6 to 11 months is a significant step — the CDC typically reserves early dosing recommendations for situations where the outbreak risk is high enough to warrant protecting babies before the standard schedule begins.

    Who Faces the Greatest Risk?

    • Unvaccinated residents of Buckingham and Cumberland Counties
    • Children under 12 months who cannot yet receive standard MMR vaccination
    • People traveling through the area who are unvaccinated or have only one documented MMR dose
    • Anyone whose vaccination history is uncertain — particularly adults born between 1957 and 1989, who may have received only one dose before two-dose schedules became standard

    Symptoms and Warning Signs to Watch For

    Measles symptoms appear 7 to 14 days after exposure and progress in a predictable pattern:

    • High fever (often above 104°F)
    • Cough, runny nose, and red, watery eyes
    • Small white spots inside the cheeks (Koplik spots — an early, distinctive sign)
    • A red blotchy rash beginning on the face and spreading downward, appearing 3 to 5 days after initial symptoms

    Infected people are contagious from four days before the rash appears through four days after. If you develop these symptoms, do not go to a medical facility without calling ahead — notify them of your possible measles exposure so they can prepare isolation protocols.

    What You Can Do Now

    • If you live in or plan to visit Buckingham or Cumberland Counties, confirm your MMR vaccination status and your children’s vaccination records.
    • Infants 6 to 11 months old in or visiting the outbreak area should receive an early MMR dose — discuss this with your pediatrician now.
    • If you are unsure whether you have had two MMR doses, contact your physician, local health department, or the VDH Record Request Portal.
    • Report symptoms consistent with measles — fever, cough, runny nose, red eyes, and rash — to your health care provider before seeking in-person care.
    • Residents can email questions to the Virginia Department of Health at epi_response@vdh.virginia.gov or contact their local health department.

    Cost and Access: What Patients Should Know

    MMR vaccine is covered at no cost under the ACA preventive services mandate for insured patients. The Vaccines for Children (VFC) program covers MMR for eligible uninsured children. Virginia health departments are providing MMR vaccination at no cost to area residents during the outbreak. Contact the Piedmont Health District for information on local vaccination clinics.

    What Happens Next

    The VDH is continuing contact tracing, case investigation, and targeted vaccination outreach in both counties. The outbreak will be declared resolved after 42 consecutive days with no new outbreak-related cases. MedicalDaily will report on any further geographic expansion and on case count updates as they are released.

    The Bottom Line

    Virginia’s measles outbreak has crossed into a second county, with 106 confirmed outbreak-associated cases and 129 statewide in 2026. Vaccination is the only tool that stops this spread. The VDH has issued specific outbreak guidance for infants as young as 6 months in the affected area — an unusually early recommendation that reflects the seriousness of the current risk. Confirm your vaccination status and your children’s MMR records now, before a potential exposure occurs.

    Source link

  • Why Cases Are Rising Worldwide and Who’s Most at Risk

    Why Cases Are Rising Worldwide and Who’s Most at Risk

    Fatty liver disease symptoms often stay quiet for years, even as fat slowly builds up inside liver cells and disrupts normal metabolism. This condition, now commonly referred to as metabolic dysfunction–associated steatotic liver disease (MASLD), has become one of the most common chronic liver disorders worldwide. Closely tied to obesity, insulin resistance, and type 2 diabetes, it reflects broader lifestyle shifts toward calorie-dense diets and reduced physical activity. Because early damage is reversible, understanding why fatty liver disease is increasing matters as much as recognizing who should be screened.

    Many people live for years without obvious fatty liver disease symptoms, only learning about the condition after routine blood tests or imaging. By the time discomfort or fatigue appears, inflammation or scarring may already be present. This makes early awareness critical, especially for adults with metabolic risk factors.

    Fatty Liver Disease Symptoms: Silent Progression and Early Warning Signs

    Fatty liver disease symptoms are absent in most people during early stages, which is why the condition is often found incidentally. Mild steatosis rarely causes pain, and liver enzymes may remain only slightly elevated. When symptoms do appear, they tend to reflect more advanced inflammation or fibrosis rather than simple fat accumulation.

    Common fatty liver disease symptoms include persistent fatigue, vague pressure or discomfort in the right upper abdomen, and reduced exercise tolerance. As scarring progresses, more serious signs can develop, such as jaundice, abdominal swelling, leg edema, or mental confusion linked to toxin buildup. These symptoms usually indicate significant liver impairment rather than early disease.

    According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), most people with fatty liver disease have no symptoms, and the condition is frequently discovered during testing for unrelated issues. The NIDDK also emphasizes that symptom severity does not reliably reflect how much liver damage is present, which is why imaging and lab tests are essential for proper assessment.

    NAFLD Causes: Why Fatty Liver Disease Is Increasing Globally

    NAFLD causes are rooted in metabolic imbalance, where excess calories overwhelm the liver’s ability to process and export fat. Insulin resistance plays a central role, driving increased fat delivery to the liver and stimulating new fat production within liver cells. Over time, this leads to triglyceride accumulation and oxidative stress.

    Several forces explain the sharp global rise in NAFLD causes. Obesity rates have climbed steadily, particularly central or visceral obesity, which directly exposes the liver to free fatty acids. Diets high in refined carbohydrates and fructose-sweetened beverages accelerate liver fat synthesis. Physical inactivity further worsens insulin resistance, while disrupted sleep and chronic stress add to metabolic strain.

    Based on a study conducted by the World Health Organization (WHO), the worldwide increase in obesity and type 2 diabetes closely parallels the rising prevalence of fatty liver disease, especially in urbanizing regions. The WHO highlights that lifestyle-driven metabolic disorders now represent a leading contributor to chronic liver disease globally.

    Fatty Liver Disease Diagnosis: Tests, Imaging, and Risk Assessment

    Fatty liver disease diagnosis usually begins with blood tests showing mildly elevated ALT or AST levels, though normal enzymes do not exclude disease. Imaging plays a key role, with ultrasound commonly identifying a “bright” liver appearance consistent with steatosis. More advanced tools help assess scarring without invasive procedures.

    Transient elastography (FibroScan) measures liver stiffness and estimates fibrosis risk, while MRI-based techniques quantify liver fat more precisely. Noninvasive scoring systems such as FIB-4 combine age, liver enzymes, and platelet counts to identify patients who need specialist referral. Liver biopsy is reserved for cases where diagnosis or staging remains unclear.

    According to the American Liver Foundation, noninvasive tests now allow clinicians to identify patients at risk for advanced fibrosis without routine biopsy. The foundation notes that early diagnosis enables lifestyle changes that can halt or reverse fatty liver disease before permanent damage occurs.

    NAFLD Treatment: Reversal, Management, and Prevention Strategies

    NAFLD treatment focuses on addressing the metabolic drivers behind liver fat accumulation. Sustained weight loss of 7–10% has been shown to significantly reduce liver fat and inflammation. Dietary patterns emphasizing whole foods, fiber, and unsaturated fats support insulin sensitivity and reduce hepatic stress.

    Regular physical activity improves liver health even without dramatic weight loss, as exercise lowers visceral fat and improves glucose control. Emerging medications such as GLP-1 receptor agonists show promise in reducing steatosis and inflammation, particularly in patients with diabetes. For individuals with severe obesity, bariatric surgery can lead to substantial improvement or resolution of fatty liver disease.

    Prevention remains central. Limiting sugary beverages, maintaining a healthy waist circumference, managing blood sugar, and monitoring cholesterol levels all reduce long-term risk. Early intervention offers the best chance to avoid progression to cirrhosis or liver cancer.

    Fatty Liver Disease and Metabolic Health: Why Early Action Matters

    Fatty liver disease reflects broader metabolic strain rather than an isolated liver problem. When liver fat builds up, it worsens insulin resistance, increases cardiovascular risk, and raises the likelihood of future diabetes complications. Addressing fatty liver disease therefore supports whole-body health, not just liver function.

    Early screening in people with obesity, diabetes, or metabolic syndrome allows clinicians to identify reversible stages. Small, consistent lifestyle changes often yield meaningful improvements within months. As global rates continue to rise, recognizing fatty liver disease as a metabolic warning sign rather than a silent incidental finding can shift outcomes toward prevention and long-term health.

    Frequently Asked Questions

    1. Is fatty liver disease always serious?

    Fatty liver disease is often mild in its early stages and may never progress in some people. However, a significant portion develop inflammation and scarring over time. The challenge is that symptoms do not reliably signal progression. Regular monitoring helps identify who needs closer care.

    2. Can fatty liver disease be reversed naturally?

    Yes, early fatty liver disease can often be reversed with sustained weight loss, dietary changes, and regular exercise. Even modest improvements in lifestyle can reduce liver fat. Consistency matters more than rapid results. Medical guidance helps tailor changes safely.

    3. Do you need alcohol to get fatty liver disease?

    No, nonalcoholic fatty liver disease occurs in people who drink little or no alcohol. It is primarily linked to metabolic factors like obesity and insulin resistance. Alcohol-related liver disease is a separate condition. Both can cause similar liver damage.

    4. Who should be screened for fatty liver disease?

    People with obesity, type 2 diabetes, metabolic syndrome, or persistently abnormal liver enzymes should be evaluated. Family history and certain ethnic backgrounds may also increase risk. Screening usually starts with blood tests and imaging. Early detection allows timely prevention strategies.



    Source link

  • Salmonella Outbreak Sickens 16, CDC Warns of More Cases

    Salmonella Outbreak Sickens 16, CDC Warns of More Cases

    A salmonella outbreak tied to frozen meals from the meal delivery service Metabolic Meals has sickened at least 16 people in 10 states, according to a CDC alert issued on September 5.

    Seven people have been hospitalized. No deaths have been reported so far.

    According to USA Today, the Centers for Disease Control and Prevention is urging customers not to eat specific meals delivered during the week of July 28, which may be contaminated.

    The CDC believes the number of sick people may grow, as it often takes weeks for infections to be reported and confirmed.

    The affected products include:

    • Four Cheese Tortellini with Pesto Sauce and Grilled Chicken – Lot Code: 25199 (Best by: Aug. 7, 2025)
    • Low Carb Chicken Teriyaki and Vegetables – Lot Code: 25202 (Best by: Aug. 5, 2025)
    • Black Garlic & Ranch Chicken Tenders with Roasted Vegetables – Lot Code: 25205 (Best by: Aug. 8, 2025)
    • Sliced Top Sirloin with Roasted Peanut Sauce and Summer Vegetables – Lot Code: 25203 (Best by: Aug. 6, 2025)
    • Additional affected lot codes: 25199, 25202, 25203, 25204, and 25205


    Consumers Urged to Discard Specific Metabolic Meals Over Illness Risk

    If you have any of these meals in your freezer or fridge, do not eat them, the CDC says. Instead, throw them away or call Metabolic Meals at 855-355-6325.

    Be sure to wash your hands, kitchen surfaces, and any items the food may have touched with hot, soapy water.

    The illnesses have been reported in these states:

    • Arkansas (1), California (3), Connecticut (1), Georgia (2), Illinois (1), Minnesota (2), Missouri (3), Texas (1), Washington (1), and Wisconsin (1).

    In a statement, the CDC said Metabolic Meals is working with investigators and has already contacted customers who received the possibly contaminated meals.

    Salmonella infections can cause diarrhea, stomach pain, fever, nausea, and vomiting. Symptoms usually appear between 6 hours to 6 days after infection and often last about a week,. ABC News said

    While most people recover on their own, young children, seniors, and people with weakened immune systems may need medical care.

    According to the CDC, 1.35 million salmonella infections happen every year in the U.S., mostly from contaminated food.

    The investigation is ongoing. Consumers are urged to stay alert for more updates and check their homes for the listed products.

    Originally published on vcpost.com

    Source link

  • DK Klinik Develops Hair Donor Index After Thousands of Clinical Cases

    DK Klinik Develops Hair Donor Index After Thousands of Clinical Cases

    In a study conducted by an internationally recognised association of hair restoration surgeons, doctors specialising in hair transplantation reported that 6 out of every 100 procedures are corrective surgeries for transplants previously conducted at black market clinics.

    Considering that not every individual who underwent a transplant at a black market clinic seeks a second operation, the actual rate of hair transplants performed in black market clinics appears to be significantly higher.

    This situation highlights an evaluation process that is far from scientific standards and lacks transparency.

    In an effort to improve transparency and scientific structure in hair transplantation, DK Klinik has introduced a new clinical evaluation system: the Hair Donor Index.

    The Hair Donor Index, created by analysing thousands of hair transplantation cases performed at the clinic over the years, was developed by DK Klinik—operating in the field of dermatology and hair transplantation in Turkey for 23 years—to grade the donor area quality of patients in preparation for hair transplantation.

    Unlike traditional approaches that often rely heavily on subjective visual inspection, DK Klinik’s Hair Donor Index scores the donor area based on four critical parameters: follicular density, donor area size, follicular unit distribution, and hair thickness.

    Each factor has a different level of influence on donor site suitability. Therefore, each score is multiplied by a specific weight, and the patient’s donor area is ultimately scored between 20 and 100 based on the weighted results.

    ‘Many hair transplant evaluations focus on how much area needs to be covered, but they rarely assess whether the donor area can sustainably provide enough grafts,’ said Prof. Dr. Ümit Kemal Şentürk, a senior executive at DK Klinik and added:

    ‘While the Norwood-Hamilton classification helps estimate how many grafts may be needed to restore coverage, it does not measure whether the donor area can supply them without risk. There has been no standardised methodology for evaluating donor sufficiency — until now. Our Hair Donor Index addresses this critical gap with a structured, data-based system.

    We have long used the Hair Donor Index to classify patient candidates in our internal case evaluations, and it has been highly beneficial. However, I believe it is important to note that this methodology is only semi-standardised, as in some cases, individual patient factors can override the four main parameters we consider.’

    Another persistent challenge for hair transplant candidates is inconsistent graft number estimations between clinics.

    While traditional scales can approximate the recipient area’s needs, the donor area’s capacity has primarily been left to subjective interpretation. This often leads to exaggerated promises and a confusing environment where clinics compete over inflated graft numbers. The Hair Donor Index aims to replace guesswork with measurable, realistic evaluations.

    Raising Global Standards

    Hair transplantation has grown increasingly global, with countries like Turkey becoming major destinations for affordable, high-quality procedures. As more patients seek multiple opinions across clinics, tools like the Hair Donor Index provide a critical layer of transparency, helping patients avoid misleading promises and make better-informed decisions.

    DK Klinik’s initiative not only sets a new benchmark for donor area evaluation but also reinforces its long-standing commitment to patient-centred, evidence-based care.

    Source link

  • Measles Outbreak in Texas County With Low Vaccination Rate Multiplies, More Cases ‘Likely’

    Measles Outbreak in Texas County With Low Vaccination Rate Multiplies, More Cases ‘Likely’

    Measles is ripping through Gaines County, Texas—cases have more than tripled, and health officials warn the worst is yet to come. The highly contagious virus is spreading fast, with more infections “likely” in the days ahead.

    The Texas Department of State Health Services (DSHS) confirmed 48 cases as of this week, up from just 14 last Friday.

    “Thirteen of the patients have been hospitalized,” the agency stated in a press release. All of the cases involve individuals who are either unvaccinated or whose vaccination status is unknown.

    “The best way to prevent getting sick is to be immunized with two doses of a vaccine against measles,” DSHS advised. The Centers for Disease Control and Prevention (CDC) notes that the measles-mumps-rubella (MMR) vaccine is 97% effective at preventing infection.

    Health officials attribute the outbreak to low vaccination rates. Only 82% of kindergartners in Gaines County public schools are up to date on their shots, well below the 95% threshold required for herd immunity. The county also has an 18% exemption rate for vaccines due to religious or personal beliefs.

    “We’re trying to get out the message about how important vaccination is,” Zach Holbrooks, executive director of the South Plains Public Health District told CNN. He stressed those exposed or symptomatic should get tested at the mobile screening unit in Seminole, Texas.

    “Measles is a serious yet preventable disease,” added Dr. Jamie Felberg of the South Plains Public Health District. “Staying up to date on vaccinations is the most effective way to safeguard yourself, your loved ones, and the community.”

    “Additional cases are likely to occur in Gaines County and the surrounding communities,” DSHS warned.

    Originally published on Latin Times

    Source link

  • Measles Outbreak in Texas County With Low Vaccination Rate Multiplies, More Cases ‘Likely’

    Measles Outbreak in Texas County With Low Vaccination Rate Multiplies, More Cases ‘Likely’

    Measles is ripping through Gaines County, Texas—cases have more than tripled, and health officials warn the worst is yet to come. The highly contagious virus is spreading fast, with more infections “likely” in the days ahead.

    The Texas Department of State Health Services (DSHS) confirmed 48 cases as of this week, up from just 14 last Friday.

    “Thirteen of the patients have been hospitalized,” the agency stated in a press release. All of the cases involve individuals who are either unvaccinated or whose vaccination status is unknown.

    “The best way to prevent getting sick is to be immunized with two doses of a vaccine against measles,” DSHS advised. The Centers for Disease Control and Prevention (CDC) notes that the measles-mumps-rubella (MMR) vaccine is 97% effective at preventing infection.

    Health officials attribute the outbreak to low vaccination rates. Only 82% of kindergartners in Gaines County public schools are up to date on their shots, well below the 95% threshold required for herd immunity. The county also has an 18% exemption rate for vaccines due to religious or personal beliefs.

    “We’re trying to get out the message about how important vaccination is,” Zach Holbrooks, executive director of the South Plains Public Health District told CNN. He stressed those exposed or symptomatic should get tested at the mobile screening unit in Seminole, Texas.

    “Measles is a serious yet preventable disease,” added Dr. Jamie Felberg of the South Plains Public Health District. “Staying up to date on vaccinations is the most effective way to safeguard yourself, your loved ones, and the community.”

    “Additional cases are likely to occur in Gaines County and the surrounding communities,” DSHS warned.

    Source link